NasdaqCM - Nasdaq Real Time Price ? USD
Cibus, Inc. (CBUS)
At close: September 13 at 4:00 PM EDT
After hours: September 13 at 4:01 PM EDT
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 3 | 3 |
| Avg. Estimate | -0.89 | -0.68 | -3.52 | -2.78 |
| Low Estimate | -0.95 | -0.96 | -4.17 | -3.31 |
| High Estimate | -0.84 | -0.4 | -2.88 | -2.43 |
| Year Ago EPS | -1.59 | -12.59 | -25.95 | -3.52 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 4 | 4 |
| Avg. Estimate | 610k | 630k | 2.44M | 8.21M |
| Low Estimate | 470k | 520k | 1.5M | 2.33M |
| High Estimate | 750k | 750k | 3M | 15M |
| Year Ago Sales | 475k | 1.1M | 1.82M | 2.44M |
| Sales Growth (year/est) | 28.40% | -42.90% | 34.30% | 236.50% |
Earnings History
| CURRENCY IN USD | 9/30/2023 | 12/31/2023 | 3/31/2024 | 6/30/2024 |
|---|---|---|---|---|
| EPS Est. | -1.17 | -1.43 | -1.01 | -0.81 |
| EPS Actual | -1.59 | -12.59 | -1.12 | -1.14 |
| Difference | -0.42 | -11.16 | -0.11 | -0.33 |
| Surprise % | -35.90% | -780.40% | -10.90% | -40.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.89 | -0.68 | -3.52 | -2.78 |
| 7 Days Ago | -0.89 | -0.68 | -3.52 | -2.78 |
| 30 Days Ago | -0.87 | -0.73 | -3.52 | -2.78 |
| 60 Days Ago | -0.76 | -0.52 | -3.05 | -2.35 |
| 90 Days Ago | -0.76 | -0.52 | -3.05 | -2.35 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | CBUS | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 44.00% | -- | -- | 5.40% |
| Next Qtr. | 94.60% | -- | -- | 9.20% |
| Current Year | 86.40% | -- | -- | 2.60% |
| Next Year | 21.00% | -- | -- | 12.90% |
| Next 5 Years (per annum) | -- | -- | -- | 11.82% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
| Maintains | Canaccord Genuity: Buy to Buy | 8/12/2024 |
| Initiated | Alliance Global Partners: Buy | 7/29/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/10/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/22/2024 |
| Reiterates | HC Wainwright & Co.: Buy | 10/9/2023 |
Related Tickers
PMN ProMIS Neurosciences, Inc.
1.2300
0.00%
HOWL Werewolf Therapeutics, Inc.
2.3400
+8.33%
GBIO Generation Bio Co.
2.6000
+2.77%
IPSC Century Therapeutics, Inc.
1.6000
+3.90%
CLLS Cellectis S.A.
2.2500
-6.25%
NKGN NKGen Biotech, Inc.
0.7736
-11.14%
LENZ LENZ Therapeutics, Inc.
21.86
+5.86%
BYSI BeyondSpring Inc.
2.3000
+5.02%
CDXS Codexis, Inc.
2.7800
+1.83%
TSVT 2seventy bio, Inc.
4.7100
+2.61%